Add to a list

Inactive Instrument

ViaDerma, Inc. Stock Other OTC

VDRM

US92555K1016

Biotechnology & Medical Research

OTC Markets Traded

ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Companyâ€™s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Companyâ€™s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Companyâ€™s subsidiary is ViaDerma, II Inc.

Employees

Sector

Biotechnology & Medical Research

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	6.31M 5.45M 5.09M 4.67M 8.79M 600M 8.93M 59.76M 23.46M 301M 23.68M 23.16M 994M	P/E 2015	10.7x	P/E 2016	-3.3x
Enterprise Value	6.6M 5.71M 5.33M 4.89M 9.2M 628M 9.35M 62.57M 24.56M 315M 24.79M 24.25M 1.04B	EV / Sales 2015	1.5x	EV / Sales 2016	3.63x
Free-Float	99%	Yield 2015 *	-	Yield 2016	-

25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	CI
24-08-13	ViaDerma, Inc. Announces Commencement of the Registration Process in Kenya, Namibia, and Tanzania for Strategic Expansion into East and Southern Africa	CI
24-08-13	ViaDerma, Inc. Announces Shipment of 500,000 Units of its Product to Nigeria	CI
24-08-01	ViaDerma, Inc. Finalizes Distribution Agreements in Dubai	CI
23-03-16	ViaDerma, Inc. Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product	CI
23-03-08	ViaDerma Announces Intent to Launch New Minoxidil Hair Regrowth Product	CI
22-09-15	ViaDerma, Inc. Successfully Completes Quality Control Testing of Its New Vitastem Products	CI
21-10-04	ViaDerma, Inc. Set to Launch Two New and Improved Versions of Its Flagship Product, Vitastem and Vitastem Ultra	CI
21-06-24	ViaDerma, Inc. Provides Updates on Current Business Activities	CI
21-06-02	ViaDerma, Inc. Announces Expansion of Its Current Licensing Agreement	CI
21-05-13	ViaDerma, Inc. Nearing Initial Order from Large Hospital Network	CI
21-04-08	ViaDerma, Inc. Provides Revenue Guidance for the First Quarter of 2021	CI
21-01-21	ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States	CI

25-07-16	ViaDerma Announces Posting of Annual Report and Ongoing Evaluation of Public Status in Response to Market Changes	AQ
25-06-04	ViaDerma, Inc. Confirms Ongoing Operations and Commitment to Regulatory Compliance	AQ
25-01-21	ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India	AQ
24-12-10	ViaDerma Announces Significant 2024 Achievements and International Expansion	AQ
24-10-03	ViaDerma, Inc. Reports Strong Financial Results for Q2 2024, Achieving Positive Net Income and Significant Cash Flow Growth	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VIADERMA, INC.	+5.85%	-24.07%	-	-	493K
LONZA GROUP AG	+0.17%	+2.36%	+5.95%	+15.12%	49.47B
REVOLUTION MEDICINES, INC.	+3.71%	+9.40%	+486.14%	+592.61%	43.97B
BEONE MEDICINES AG	+5.60%	+10.21%	+20.85%	+73.63%	39.6B
IQVIA HOLDINGS INC.	+2.70%	+1.57%	+32.71%	+9.15%	39.29B
CELLTRION, INC.	+2.21%	+6.75%	+20.20%	+47.53%	32.43B
ASCENDIS PHARMA A/S	+2.23%	+4.71%	-	-	16.84B
MEDPACE HOLDINGS, INC.	+0.97%	+2.35%	+35.99%	+122.50%	16.49B
EUROFINS SCIENTIFIC SE	-0.23%	+2.80%	+5.10%	+18.11%	14.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.75%	+15.04%	+79.84%	+23.95%	12.77B
Average	+2.40%	+6.32%	+85.85%	+112.83%	29.43B
Weighted average by Cap.	+2.38%	+6.10%	+105.31%	+137.89%

	2015	2016
Net sales	192K 166K 155K 142K 267K 18.25M 272K 1.82M 713K 9.15M 720K 704K 30.24M	252K 218K 204K 187K 351K 23.98M 357K 2.39M 937K 12.02M 946K 926K 39.74M
Net income	27.12K 23.46K 21.91K 20.1K 37.8K 2.58M 38.4K 257K 101K 1.29M 102K 99.62K 4.28M	-122K -105K -98.39K -90.26K -170K -11.59M -172K -1.15M -453K -5.81M -457K -447K -19.21M
Net Debt	288K 249K 233K 214K 402K 27.43M 408K 2.73M 1.07M 13.75M 1.08M 1.06M 45.45M	297K 257K 240K 220K 414K 28.25M 420K 2.81M 1.1M 14.16M 1.11M 1.09M 46.8M

ViaDerma, Inc. Stock Other OTC

Stocks

VDRM

US92555K1016

Biotechnology & Medical Research

Valuation: ViaDerma, Inc.

Latest news : ViaDerma, Inc.

Press Releases: ViaDerma, Inc.

Quotes and Performance

Managers and Directors: ViaDerma, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile